(Q41731227)

8 October 2017

1 reference

title

Anticoagulation in dilated cardiomyopathy (English)

1 reference

8 October 2017

1 reference

Koniaris LS

1

1 reference

8 October 2017

Goldhaber SZ

series ordinal

2

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Journal of the American College of Cardiology

8 October 2017

published in

1 reference

8 October 2017

volume

31

1 reference

8 October 2017

issue

4

1 reference

8 October 2017

page(s)

745-748

1 reference

Idiopathic myocardial hypertrophy

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

The natural history of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Low incidence of stroke in ambulatory patients with heart failure: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Risk of arterial embolization in 224 patients awaiting cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

The effect of warfarin on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Ventricular dysfunction and the risk of stroke after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

A plea for a clinical trial of anticoagulation in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

Left Ventricular Thrombi and Cerebral Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900003-5

7 January 2021

10.1016/S0735-1097(98)00003-5

Identifiers

DOI

1 reference

8 October 2017

1 reference